Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Molecular Dynamics Simulations Support Multiple Binding Sites for Phospholamban on SERCA

View through CrossRef
Ion‐motive ATPases use the energy of ATP hydrolysis to transport ions across membrane bilayer against a concentration gradient. Here we investigate the functional regulation of the sarco(endo)plasmic reticulum calcium ATPase (SERCA), which plays a key role in cellular Ca handling. In the heart, the activity of the SERCA is regulated by its inhibitory partner phospholamban (PLB). PLB has been shown to inhibit the transporter by binding to the SERCA M6 helix, but this site is not available when SERCA is bound to Ca. Our previous fluorescence resonance energy transfer (FRET) experiments suggested that SERCA Ca binding causes PLB to translocate from the known binding site to a putative secondary site. Based on an analogous interaction of the sodium/potassium ATPase (NKA) with a regulatory partner (FXYD10), we hypothesized that PLB could interact with the M9 helix on SERCA after leaving the canonical binding site. In the present study we performed molecular dynamics simulations to compare the energetics of binding of PLB to candidate sites on SERCA. We created models of the regulatory complex using structural information from available crystal structures of the PLB‐SERCA and FXYD10‐NKA complexes. Quantification of the interaction energies of these models suggested PLB can form a stable complex with both the canonical (−856 kJ/mol) and the proposed secondary site (−510 kJ/mol). In contrast, docking of PLB to the M3 helix on the opposite side of SERCA shows a much less favorable interaction energy (−108 kJ/mol). We also used umbrella sampling to quantify the free energy of PLB bound to several candidate binding sites on SERCA transmembrane domain. The results provide insight into the relative affinity of PLB for plausible sites of interaction on SERCA. Overall, the molecular dynamics simulations support a 2‐site model in which PLB interacts first with the high affinity conventional site and then relocates to a nearby secondary site when SERCA binds calcium.
Title: Molecular Dynamics Simulations Support Multiple Binding Sites for Phospholamban on SERCA
Description:
Ion‐motive ATPases use the energy of ATP hydrolysis to transport ions across membrane bilayer against a concentration gradient.
Here we investigate the functional regulation of the sarco(endo)plasmic reticulum calcium ATPase (SERCA), which plays a key role in cellular Ca handling.
In the heart, the activity of the SERCA is regulated by its inhibitory partner phospholamban (PLB).
PLB has been shown to inhibit the transporter by binding to the SERCA M6 helix, but this site is not available when SERCA is bound to Ca.
Our previous fluorescence resonance energy transfer (FRET) experiments suggested that SERCA Ca binding causes PLB to translocate from the known binding site to a putative secondary site.
Based on an analogous interaction of the sodium/potassium ATPase (NKA) with a regulatory partner (FXYD10), we hypothesized that PLB could interact with the M9 helix on SERCA after leaving the canonical binding site.
In the present study we performed molecular dynamics simulations to compare the energetics of binding of PLB to candidate sites on SERCA.
We created models of the regulatory complex using structural information from available crystal structures of the PLB‐SERCA and FXYD10‐NKA complexes.
Quantification of the interaction energies of these models suggested PLB can form a stable complex with both the canonical (−856 kJ/mol) and the proposed secondary site (−510 kJ/mol).
In contrast, docking of PLB to the M3 helix on the opposite side of SERCA shows a much less favorable interaction energy (−108 kJ/mol).
We also used umbrella sampling to quantify the free energy of PLB bound to several candidate binding sites on SERCA transmembrane domain.
The results provide insight into the relative affinity of PLB for plausible sites of interaction on SERCA.
Overall, the molecular dynamics simulations support a 2‐site model in which PLB interacts first with the high affinity conventional site and then relocates to a nearby secondary site when SERCA binds calcium.

Related Results

Protein Docking and Steered Molecular Dynamics Reveal Alternative Regulatory Sites on the SERCA Calcium Transporter
Protein Docking and Steered Molecular Dynamics Reveal Alternative Regulatory Sites on the SERCA Calcium Transporter
AbstractThe transport activity of the calcium ATPase SERCA is modulated by an inhibitory interaction with a 52-residue transmembrane peptide, phospholamban (PLB). Biochemical and s...
Sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity during the transition to endothermy in an altricial bird
Sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity during the transition to endothermy in an altricial bird
ABSTRACTSarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) is a transmembrane pump critical to muscle calcium cycling during contraction, and SERCA has also been proposed as the basi...
Ksiądz Idzi Benedykt Radziszewski – czciciel Serca Jezusowego
Ksiądz Idzi Benedykt Radziszewski – czciciel Serca Jezusowego
Obecna od dawna w Kościele idea Serca Jezusowego zaczęła przybierać formę kultu od XVII wieku. Decydującą rolę odegrały objawienia otrzymane przez św. Małgorzatę Alacoque, ale wiel...
Ca2+‐pumps and Na+–Ca2+‐exchangers in coronary artery endothelium versus smooth muscle
Ca2+‐pumps and Na+–Ca2+‐exchangers in coronary artery endothelium versus smooth muscle
AbstractVascular endothelial cells (EC) and smooth muscle cells (SMC) require a decrease in cytoplasmic Ca2+ concentration after activation. This can be achieved by Ca2+ sequestrat...
Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation
Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation
AbstractSignal transducer and activator of transcription 3 (STAT3) is an anti‐cancer target protein due to its over‐activation in tumor cells. The Tyr705‐phosphorylated (pTyr) STAT...
Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
The human papillomavirus E7 gene can transform murine fibroblasts and cooperate with other viral oncogenes in transforming primary cell cultures. One biochemical property associate...
Unidirectional potentiation of binding between two anti‐FBP MAbs: Evaluation of involved mechanisms
Unidirectional potentiation of binding between two anti‐FBP MAbs: Evaluation of involved mechanisms
AbstractThe monoclonal antibody MOv19 directed to a folate binding protein shows temperature‐dependent potentiation of binding of the noncompeting monoclonal antibody MOv18 to the ...

Back to Top